The investment seeks is to achieve 3 times (300%) the income generated from selling options on the S&P Biotechnology Select Industry Index (the “underlying index”) by selling options on leveraged exchange-traded funds designed to deliver 3 times (300%) the daily performance of the underlying index (the “Underlying Leveraged ETF”)... Show more
Category Trading